- In February 2025, Capgemini unveiled a cutting-edge generative AI methodology for protein engineering, powered by a proprietary protein large language model (pLLM). Designed to predict the most effective protein variants, this innovative approach—currently patent-pending—aims to accelerate progress in the global bioeconomy and drive transformative breakthroughs across sectors such as healthcare, agriculture, and environmental science.
- In November 2024, Cradle Bio announced a USD 73 million Series B funding round led by IVP, bringing its total funding to over USD 100 million. This significant investment highlights the company’s rapid growth as it continues to revolutionize protein engineering with its AI-driven platform, poised to impact a wide range of industries—from therapeutics to agriculture.
- In June 2024, Evolutionary Scale, an AI-focused biology startup, secured USD 142 million in seed funding to develop large language models aimed at creating novel proteins and biological systems. Their innovations are expected to accelerate drug discovery and environmental applications, such as engineering microbes to break down plastics
